• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Comprehensive Overview of tert-butyl (2R)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (CAS No. 2296776-01-5)

The compound tert-butyl (2R)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (CAS No. 2296776-01-5) is a highly specialized boron-containing intermediate widely used in pharmaceutical research and organic synthesis. Its unique structure, featuring a tetramethyl-1,3,2-dioxaborolane moiety and a piperidine ring, makes it invaluable for Suzuki-Miyaura cross-coupling reactions, a cornerstone in modern drug discovery. Researchers frequently search for "boronic ester applications" or "chiral piperidine derivatives," reflecting its relevance in asymmetric synthesis and medicinal chemistry.

In recent years, the demand for enantiomerically pure intermediates like this compound has surged due to advancements in targeted drug delivery and precision medicine. Its CAS No. 2296776-01-5 is often queried alongside terms such as "boronate stability" and "N-Boc protection strategies," highlighting its role in optimizing reaction conditions. The tert-butyl carbamate (Boc) group enhances solubility and stability, addressing common challenges in peptide synthesis—a topic trending in AI-driven molecular design forums.

From a synthetic perspective, the tetramethyl-1,3,2-dioxaborolane unit offers exceptional hydrolytic stability, a feature critical for high-throughput screening workflows. This aligns with industry searches for "water-tolerant boronic acids" and "green chemistry alternatives." Moreover, the compound’s (2R)-stereochemistry caters to the growing focus on chiral auxiliaries, as evidenced by its inclusion in studies on kinetic resolution and enzyme-catalyzed reactions.

Analytical techniques such as NMR spectroscopy and HPLC chiral separation are essential for characterizing tert-butyl (2R)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate. These methods are frequently discussed in relation to "quality control in API manufacturing," a hot topic in regulatory compliance circles. The compound’s compatibility with microwave-assisted synthesis also positions it as a candidate for flow chemistry applications, another area gaining traction in process optimization debates.

Beyond pharmaceuticals, this boron-based derivative finds niche applications in material science, particularly in designing self-healing polymers—a subject often explored in nanotechnology research. Its CAS No. 2296776-01-5 is occasionally linked to queries about "boron neutron capture therapy (BNCT)," though its primary utility remains in small-molecule development. As the industry shifts toward sustainable catalysis, the compound’s role in metal-free coupling reactions further underscores its versatility.

In summary, tert-butyl (2R)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate exemplifies the intersection of chiral synthesis and boron chemistry. Its adaptability to high-efficiency transformations and alignment with cutting-edge research trends ensure its continued prominence in both academic and industrial settings.

• 2071192-55-5(tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate)
• 2071192-58-8(tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate)
• 1425335-44-9(tert-butyl 4-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]piperidine-1-carboxylate)
• 149682-82-6(tert-butyl (2S)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate)
• 149682-81-5(tert-butyl (2R)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate)
• 2365173-87-9(tert-butyl 3-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]piperidine-1-carboxylate)
• 811439-53-9(tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate)
• 1312713-37-3(tert-butyl 3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate)
• 1048970-17-7(tert-butyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate)
• 2375451-09-3(tert-butyl (2S)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate)